Financial Review: Maximus (NYSE:MMS) & Research Solutions (NASDAQ:RSSS)

Maximus (NYSE:MMSGet Free Report) and Research Solutions (NASDAQ:RSSSGet Free Report) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk.

Profitability

This table compares Maximus and Research Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Maximus 5.28% 21.95% 9.60%
Research Solutions -4.57% 8.43% 2.71%

Insider & Institutional Ownership

97.2% of Maximus shares are owned by institutional investors. Comparatively, 33.6% of Research Solutions shares are owned by institutional investors. 1.6% of Maximus shares are owned by company insiders. Comparatively, 12.9% of Research Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Maximus and Research Solutions, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maximus 0 0 1 0 3.00
Research Solutions 0 0 2 0 3.00

Maximus currently has a consensus price target of $90.00, suggesting a potential upside of 34.07%. Research Solutions has a consensus price target of $5.50, suggesting a potential upside of 43.60%. Given Research Solutions’ higher probable upside, analysts clearly believe Research Solutions is more favorable than Maximus.

Valuation and Earnings

This table compares Maximus and Research Solutions”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Maximus $5.31 billion 0.72 $306.91 million $4.65 14.44
Research Solutions $44.62 million 2.82 -$3.79 million ($0.08) -47.88

Maximus has higher revenue and earnings than Research Solutions. Research Solutions is trading at a lower price-to-earnings ratio than Maximus, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Maximus has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Comparatively, Research Solutions has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500.

Summary

Maximus beats Research Solutions on 9 of the 13 factors compared between the two stocks.

About Maximus

(Get Free Report)

Maximus, Inc. operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; system implementation project management services; and specialized consulting services. The U.S. Federal Services segment offers Business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, including application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, and infrastructure and engineering solutions. The Outside the U.S. segment offers BPS solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia.

About Research Solutions

(Get Free Report)

Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets. The company also offers Article Galaxy, a solution that allows research organizations to load their entitlements, consisting of subscriptions, discount or token packages, and their existing library of articles. In addition, it provides Manage platform, a references solution that allows users to access the article inside the platform including setting up personal folders or team folders and allows researchers to markup and take notes on the articles in a supported browser on a desktop or tablet. Further, the company’s platform facilitates the sale of published STM content sold as individual articles. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada.

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.